New Delhi, Jan. 20 -- Over the past decades, developing controlled drug delivery has become increasingly important in the pharmaceutical industry, considering unmet medical needs, and advancement in drug delivery methodologies.
Transdermal drug delivery system can deliver the drugs through the skin portal to systemic circulation at a predetermined rate and maintain clinically the effective concentrations over a prolonged period of time.
The global transdermal drug delivery devices (TDDD) market to reach US$ 8.8 Billion in 2025, growing at a CAGR of 2.5% over the forecast period, driven by long-lasting therapeutic effect, lesser side-effects, better bioavailability and patient compliance as well as easy termination of drug therapy.
The gl...